REVB 13F Filings: Institutional Buyers & Sellers

On July 10, 2026, the board of Revelation Biosciences adopted a stockholder rights plan, commonly known as a "poison pill." The plan issues one right per share of common stock to shareholders of record on July 21, 2026. Each right initially allows the holder to buy a fraction of preferred stock at $20.00, but the rights only become exercisable if a person or group acquires 10% or more of the company's common stock without board approval. If triggered, the rights let other shareholders purchase additional common stock at a discount, diluting the acquirer's stake.